Focal Therapeutics, Inc.

MA · United States · Reporting entity ID 100000141524

Total reported 2019–2025

$431K

#1,630 of 2,960 reporting companies — 0% of all reported industry payments

$345K in general payments across 821 records, plus $86K in research funding across 14 records.

How it breaks down

General payments $344,823

Research funding $86,015

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.